SIRT6 and neoplasm: In conclusion, the capacity of SIRT6 to function as a tumor suppressor, particularly through its modulation of pathways such as Lin28b, highlights its therapeutic promise for specific PDAC subtypes that rely on these epigenetic mechanisms for growth and survival.